ALLMedicine™ Peripheral Neuropathy Center
Research & Reviews 3,095 results
https://doi.org/10.2337/dc20-1027
Diabetes Care; Riley J, Antza C et. al.
Jan 23rd, 2021 - To investigate the relationship between social deprivation and incident diabetes-related foot disease (DFD) in newly diagnosed patients with type 2 diabetes. A population-based open retrospective cohort study using The Health Improvement Network (...
https://doi.org/10.1073/pnas.2012685118
Proceedings of the National Academy of Sciences of the Un... Pero ME, Meregalli C et. al.
Jan 20th, 2021 - The pathogenesis of chemotherapy-induced peripheral neuropathy (CIPN) is poorly understood. Here, we report that the CIPN-causing drug bortezomib (Bort) promotes delta 2 tubulin (D2) accumulation while affecting microtubule stability and dynamics ...
https://doi.org/10.1111/jns.12432
Journal of the Peripheral Nervous System : JPNS; Wei G, Gu Z et. al.
Jan 19th, 2021 - Oxaliplatin-induced peripheral neuropathy (OIPN) is a common and dose-limiting toxic effect that markedly limits the use of oxaliplatin and affects the quality of life. Although it is common, the underlying mechanisms of OIPN remain ambiguous. Rec...
https://doi.org/10.1111/cts.12977
Clinical and Translational Science; Kessler JA, Shaibani A et. al.
Jan 19th, 2021 - VM202 is a plasmid DNA encoding two isoforms of hepatocyte growth factor (HGF). A previous Phase 2 study in subjects with painful diabetic peripheral neuropathy (DPN) showed significant reductions in pain. A Phase 3 study was conducted to evaluate...
https://doi.org/10.1007/s11154-020-09619-9 10.1001/jama.293.2.217 10.4314/ahs.v17i2.21 10.1111/j.1464-5491.1992.tb01819.x 10.2466/pms.104.1.56-66 10.1016/j.jdiacomp.2005.06.004 10.1097/JPO.0b013e3181f25071 10.1016/S0168-8227(97)00044-2 10.2337/diacare.17.12.1411 10.2519/jospt.1999.29.12.718 10.1002/dmrr.2702 10.12968/jowc.2015.24.12.560 10.1111/j.1532-5415.1997.tb00979.x 10.1111/j.1532-5415.1998.tb06002.x 10.1177/1932296814546528 10.1186/s13047-016-0172-3 10.2337/dc13-0429 10.1016/j.clinbiomech.2015.09.013 10.1093/ptj/83.8.713 10.1016/j.jclinepi.2009.06.006 10.1177/0309364614543549 10.1016/j.clinbiomech.2019.06.015 10.1016/j.gaitpost.2009.02.012 10.1177/193229681300700506 10.7547/1030508 10.1016/j.foot.2015.02.004 10.1093/ageing/24.1.67 10.1186/1757-1146-5-11 10.1177/0309364615588342 10.1016/j.jbmt.2014.11.002 10.1186/s12877-017-0613-2 10.1371/journal.pone.0047963 10.1016/j.gaitpost.2016.02.018 10.1016/j.gaitpost.2013.08.011 10.1016/j.jelekin.2017.01.005 10.1111/j.1532-5415.1992.tb01795.x 10.1016/j.apmr.2008.02.031 10.1159/000115850 10.1111/j.1532-5415.1999.tb01589.x 10.1111/j.1532-5415.2004.52507.x 10.7547/1030165 10.1682/JRRD.2008.02.0023 10.1016/j.apmr.2014.10.004 10.1016/j.gerinurse.2012.01.007 10.1016/j.apergo.2014.06.005 10.1155/2016/9305025 10.1016/j.jbiomech.2004.03.025 10.1016/j.gaitpost.2006.04.013 10.1016/j.humov.2007.08.003 10.4103/0022-3859.128805
Reviews in Endocrine & Metabolic Disorders; Horstink KA, van der Woude LHV et. al.
Jan 16th, 2021 - Patients with diabetic peripheral neuropathy (DPN) usually have reduced somatosensory information and altered perception in feet and ankles. Somatosensory information acts as feedback for movement control and loss of somatosensation leads to alter...
Guidelines 2 results
https://doi.org/10.1016/j.numecd.2013.12.007
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Aiello A, Anichini R et. al.
Feb 3rd, 2014 - Diabetic foot (DF) is a chronic and highly disabling complication of diabetes. The prevalence of peripheral arterial disease (PAD) is high in diabetic patients and, associated or not with peripheral neuropathy (PN), can be found in 50% of cases of...
https://doi.org/10.1002/dmrr.1225
Diabetes/metabolism Research and Reviews; Tesfaye S, Vileikyte L et. al.
Jun 22nd, 2011 - Painful diabetic peripheral neuropathy (DPN) is common, is associated with significant reduction in quality of life and poses major treatment challenges to the practising physician. Although poor glucose control and cardiovascular risk factors hav...
Drugs 287 results see all →
Clinicaltrials.gov 3,481 results
https://doi.org/10.2337/dc20-1027
Diabetes Care; Riley J, Antza C et. al.
Jan 23rd, 2021 - To investigate the relationship between social deprivation and incident diabetes-related foot disease (DFD) in newly diagnosed patients with type 2 diabetes. A population-based open retrospective cohort study using The Health Improvement Network (...
https://doi.org/10.1073/pnas.2012685118
Proceedings of the National Academy of Sciences of the Un... Pero ME, Meregalli C et. al.
Jan 20th, 2021 - The pathogenesis of chemotherapy-induced peripheral neuropathy (CIPN) is poorly understood. Here, we report that the CIPN-causing drug bortezomib (Bort) promotes delta 2 tubulin (D2) accumulation while affecting microtubule stability and dynamics ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1beb5954-fdb2-47d0-9ca1-586df00ba915
Jan 19th, 2021 - CYMBALTA ® is indicated for the treatment of: Major Depressive Disorder [see Clinical Studies ( 14.1)] Generalized Anxiety Disorder [see Clinical Studies ( 14.2)] Diabetic Peripheral Neuropathy [see Clinical Studies ( 14.3)] Fibromyalgia [see Clin...
https://doi.org/10.1111/jns.12432
Journal of the Peripheral Nervous System : JPNS; Wei G, Gu Z et. al.
Jan 19th, 2021 - Oxaliplatin-induced peripheral neuropathy (OIPN) is a common and dose-limiting toxic effect that markedly limits the use of oxaliplatin and affects the quality of life. Although it is common, the underlying mechanisms of OIPN remain ambiguous. Rec...
https://doi.org/10.1111/cts.12977
Clinical and Translational Science; Kessler JA, Shaibani A et. al.
Jan 19th, 2021 - VM202 is a plasmid DNA encoding two isoforms of hepatocyte growth factor (HGF). A previous Phase 2 study in subjects with painful diabetic peripheral neuropathy (DPN) showed significant reductions in pain. A Phase 3 study was conducted to evaluate...
News 117 results
https://www.staging.medscape.com/viewarticle/939429
Oct 19th, 2020 - Abnormal mitochondrial activity in pain-processing areas of the brain may explain why some persons with type 2 diabetes experience painful peripheral neuropathy while others do not, new U.K. study findings have suggested. A greater ratio of adenos...
https://www.medscape.com/viewarticle/939429
Oct 19th, 2020 - Abnormal mitochondrial activity in pain-processing areas of the brain may explain why some persons with type 2 diabetes experience painful peripheral neuropathy while others do not, new U.K. study findings have suggested. A greater ratio of adenos...
https://www.staging.medscape.com/viewarticle/932309
Jun 15th, 2020 - Takeaway This study suggests that vitamin D deficiency (<20 ng/mL) and insufficiency (<30 ng/mL) are associated with an increased risk of painful diabetic neuropathy (PDN). Why this matters Findings warrant a well-constructed clinical trial of vit...
https://www.medscape.com/viewarticle/932309
Jun 15th, 2020 - Takeaway This study suggests that vitamin D deficiency (<20 ng/mL) and insufficiency (<30 ng/mL) are associated with an increased risk of painful diabetic neuropathy (PDN). Why this matters Findings warrant a well-constructed clinical trial of vit...
https://www.medscape.com/viewarticle/926002
Mar 1st, 2020 - NATIONAL HARBOR, Maryland ― Combined electrochemical treatment (CET), a technique that uses local nerve blocks in conjunction with electric cell signaling, regenerates nerve fibers and significantly reduces pain for patients with peripheral neurop...
